Diabetes mellitus and breast cancer: A retrospective population-based cohort study

Breast Cancer Research and Treatment

Volumn 98, Issue 3, 2006, Pages 349-356

  Lipscombe, Lorraine L ^a,b,d   Goodwin, Pamela J ^b,c,e,f   Zinman, Bernard ^b,e,f   McLaughlin, John R ^c,f   Hux, Janet E ^a,b,c,d  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Breast cancer; Cohort study; Diabetes; Epidemiology; Insulin resistance; Risk

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERINSULINEMIA; INCOME; INSULIN RESISTANCE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGE FACTORS; AGED; BREAST NEOPLASMS; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33746866265     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9172-5     Document Type: Article

References (52)

1. American Cancer Society. Cancer facts and figures, 2003-2004. 2005: American Cancer Society, 2004
2. Thomas HV, Reeves GK, Key TJ: Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control 8: 922-928, 1997
3. ESHRE Capri Workshop Group Hormones and breast cancer. Hum Reprod Update 10: 281-293, 2004
4. Key TJ, Verkasalo PK, Banks E: Epidemiology of breast cancer. Lancet Oncol 2: 133-140, 2001
5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288: 321-333, 2002
6. Cleary MP, Maihle NJ: The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc Soc Exp Biol Med 216: 28-43, 1997
7. Harvie M, Hooper L, Howell AH: Central obesity and breast cancer risk: a systematic review. Obes Rev 4: 157-173, 2003
8. Huang Z, Willett WC, Colditz GA, Hunter DJ, Manson JE, Rosner B, Speizer FE, Hankinson SE: Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 150: 1316-1324, 1999
9. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB: Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 131: 794-803, 1990
10. Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB, Splansky GL, Anderson KM, Helsel WE: Body fat distribution and breast cancer in the Framingham Study. J Natl Cancer Inst 82: 286-290, 1990
11. van der Burg B, Rutteman GR, Blankenstein MA, de Laat SW, van Zoelen EJ: Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134: 101-108, 1988
12. Belfiore A, Frittitta L, Costantino A, Frasca F, Pandini G, Sciacca L, Goldfine ID, Vigneri R: Insulin receptors in breast cancer. Ann NY Acad Sci 784: 173-188, 1996
13. Mathieu MC, Clark GM, Allred DC, Goldfine ID, Vigneri R: Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians 109: 565-571, 1997
14. Papa V, Belfiore A: Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest 19: 324-333, 1996
15. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ: Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120, 1998
16. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20: 42-51, 2002
17. Hirose K, Toyama T, Iwata H, Takezaki T, Hamajima N, Tajima K: Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women. Asian Pac J Cancer Prev 4: 239-246, 2003
18. Lawlor DA, Smith GD, Ebrahim S: Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15: 267-275, 2004
19. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ: Insulin resistance and breast-cancer risk. Int J Cancer 52: 511-516, 1992
20. Yang G, Lu G, Jin F, Dai Q, Best R, Shu XO, Chen JR, Pan XY, Shrubsole M, Zheng W: Population-based, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 1207-1211, 2001
21. Nyholm H, Djursing H, Hagen C, Agner T, Bennett P, Svenstrup B: Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 69: 946-949, 1989
22. Buchanan TA: Pancreatic beta-cell loss and preservation in type 2 diabetes. Clin Ther 25(Suppl B): B32-B46, 2003
23. Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A: Risk factors for male breast cancer-a case-control study from Scandinavia. Acta Oncol 40: 467-471, 2001
24. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER: Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12: 875-880, 2001
25. Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P: Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26: 781-785, 1990
26. Kopp S, Tanneberger S, Mohner M, Kieser R.: Diabetes and breast cancer risk. Int J Cancer 46: 751-752, 1990
27. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P: A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70: 950-953, 1994
28. Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB: Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28: 816-823, 1999
29. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE: Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26: 1752-1758, 2003
30. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202, 2005
31. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR: Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156: 349-352, 2002
32. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO: Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71: 360-363, 1997
33. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH: Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365, 1997
34. Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS: Screening mammogram utilization in women with diabetes. Diabetes Care 24: 2049-2053, 2001
35. Hux JE, Tang M: Chapter 1: Patterns of prevalence and incidence of daibetes. In: Hux JE, Booth G, Laupacis A (eds) Diabetes in Ontario: An ICES Practice Atlas. Institute for Clinical Evaluative Sciences, Toronto, Canada 2003
36. Bruning PF, Bonfrer JM, Hart AA, van Noord PA, van der Hoeven H, Collette HJ, Battermann JJ, de Jong-Bakker M, Nooijen WJ, de Waard F: Body measurements, estrogen availability and the risk of human breast cancer: a case-control study. Int J Cancer 51: 14-19, 1992
37. Steppel JH, Horton ES: Beta-cell failure in the pathogenesis of type 2 diabetes mellitus. Curr Diab Rep 4: 169-175, 2004
38. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R: Factors influencing the age at natural menopause. J Chronic Dis 40: 995-1002, 1987
39. August DA, Rea T, Sondak VK: Age-related differences in breast cancer treatment. Ann Surg Oncol 1: 45-52, 1994
40. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88: 716-726, 1996
41. Louwman WJ, Janssen-Heijnen ML, Houterman S, Voogd AC, van der Sangen MJ, Nieuwenhuijzen GA, Coebergh JW: Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer 41: 779-785, 2005
42. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285: 885-892, 2001
43. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25: 512-516, 2002
44. Robles SC, Marrett LD, Clarke EA, Risch HA: An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41: 495-501, 1988
45. McLaughin JR, Sloan MR, Janovjak DP: Cancer survival in Ontario. The Ontario Cancer Treatment and Research Foundation: 1-9, 1995
46. Weiner JP, Starfield BH, Steinwachs DM, Mumford LM: Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 29: 452-472, 1991
47. Weiner JP, Abrams C: ACG Software Documentation/Users Manual, Version 5.0. Johns Hopkins University, 2001
48. Shah BR, Mamdani M, Kopp A: Chapter 3: Drug use in older people with diabetes. In: Hux JE, Booth G, Laupacis A (eds) Diabetes in Ontario: An ICES Practice Atlas. Institute for Clinical Evaluative Sciences, Toronto, Canada 2003
49. Gerber M: Re: "Body size and breast cancer risk among women under age 45 years". Am J Epidemiol 145: 669-670, 1997
50. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ: Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167, 2004
51. Lipscombe LL, Hux JE, Booth GL: Reduced screening mammography among women with diabetes. Arch Intern Med 165: 2090-2095, 2005
52. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053, 2004